Association between the tryptophan hydroxylase-1 gene A218C polymorphism and citalopram antidepressant response in a Korean population

Progress in Neuro-Psychopharmacology and Biological Psychiatry

Volumn 31, Issue 1, 2007, Pages 104-107

  Ham, Byung Joo ^a   Lee, Boung Chul ^a   Paik, Jong Woo ^b   Kang, Rhee Hun ^b   Choi, Myoung Jin ^b   Choi, Ihn Geun ^a   Lee, Min Soo ^b  

^a Hallym University Medical Center   (South Korea)

^b Korea University College of Medicine   (South Korea)

Author keywords

Citalopram; Major depressive disorder; Polymorphism; Tryptophan hydroxylase

Indexed keywords

ANTIDEPRESSANT AGENT; CITALOPRAM; SEROTONIN UPTAKE INHIBITOR; TRYPTOPHAN HYDROXYLASE; TRYPTOPHAN HYDROXYLASE A218C; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; DEPRESSION; DRUG ACTIVITY; DRUG RESPONSE; FEMALE; GENE; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENOTYPE; HAMILTON SCALE; HUMAN; HUMAN CELL; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; RECEPTOR AFFINITY; REMISSION; SEROTONIN RELEASE; TPH1 GENE;

ADULT; ALLELES; ANTIDEPRESSIVE AGENTS; CITALOPRAM; DEPRESSIVE DISORDER; DNA; FEMALE; GENOTYPE; HUMANS; KOREA; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC; PSYCHIATRIC STATUS RATING SCALES; RECEPTOR, SEROTONIN, 5-HT2A; TREATMENT OUTCOME; TRYPTOPHAN HYDROXYLASE;

EID: 33845760846     PISSN: 02785846     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pnpbp.2006.08.001     Document Type: Article

References (29)

1. Abbar M., Courtet P., Amadeo S., Caer Y., Mallet J., Baldy-Moulinier M., et al. Suicidal behaviors and the tryptophan hydroxylase gene. Arch Gen Psychiatry 52 (1995) 846-849
2. Arias B., Catalan R., Gasto C., Gutierrez B., and Fananas L. 5-HTTLPR polymorphism of the serotonin transporter gene predicts non-remission in major depression patients treated with citalopram in a 12-weeks follow up study. J Clin Psychopharmacol 23 (2003) 563-567
3. Bellivier F., Leboyer M., Courtet P., Buresi C., Beaufils B., Samolyk D., et al. Association between the tryptophan hydroxylase gene and manic-depressive illness. Arch Gen Psychiatry 55 (1998) 33-37
4. Boularand S., Darmon M.C., Ganem Y., Launay J.M., and Mallet J. Complete coding sequence of human tryptophan hydroxylase. Nucleic Acids Res 18 (1990) 4257
5. Buchner A., Faul F., and Erdfelder E. G·Power: a priori, post-hoc, and compromise power analyses for the Macintosh (Version 2.1.1) [Computer program] (1996), University of Trier, Trier
6. Cervo L., Canetta A., Calcagno E., Burbassi S., Sacchetti G., Caccia S., et al. Genotype-dependent activity of tryptophan hydroxylase-2 determines the response to citalopram in a mouse model of depression. J Neurosci 25 (2005) 8165-8172
7. Choi M.J., Kang R.H., Ham B.J., Jeong H.Y., and Lee M.S. Serotonin receptor 2A gene polymorphism (- 1438A/G) and short-term treatment response to citalopram. Neuropsychobiology 52 (2005) 155-162
8. Craig S.P., Boularand S., Darmon M.C., Mallet J., and Craig I.W. Localization of human tryptophan hydroxylase (TPH) to chromosome 11p15.3-p14 by in situ hybridization. Cytogenet Cell Genet 56 (1991) 157-159
9. Evans J., Reeves B., Platt H., Leibenau A., Goldman D., Jefferson K., et al. Impulsiveness, serotonin genes and repetition of deliberate self-harm (DSH). Psychol Med 30 (2000) 1327-1334
10. Ham B.J., Lee M.S., Lee H.J., Kang R.H., Han C.S., Choi M.J., et al. No association between the tryptophan hydroxylase gene polymorphism and major depressive disorders and antidepressant response in a Korean population. Psychiatr Genet 15 (2005) 299-301
11. Hamilton M. Development of a rating scale for primary depressive illness. Br J Soc Clin Psychol 6 (1967) 278-296
12. Han O.S., and Hong J.P. Structured clinical interview for DSM-IV axis I disorder-Korean version (2000), Hana Medical Publishing Co., Seoul
13. Hong C.J., Chen T.J., Yu Y.W., and Tsai S.J. Response to fluoxetine and serotonin 1A receptor (C-1019G) polymorphism in Taiwan Chinese major depressive disorder. Pharmacogenomics J 6 (2006) 27-33
14. Hyttel J. Pharmacological characterization of selective serotonin reuptake inhibitors (SSRIs). Int Clin Psychopharmacol 9 (1994) 19-26 [Suppl 1]
15. Ishiguro H., Saito T., Shibuya H., Toru M., and Arinami T. The 5′ region of the tryptophan hydroxylase gene: mutation search and association study with alcoholism. J Neural Transm 106 (1999) 1017-1025
16. Jonsson E.G., Goldman D., Spurlock G., Gustavsson J.P., Nielsen D.A., Linnoila M., et al. Tryptophan hydroxylase and catechol-O-methyltransferase gene polymorphisms: relationships to monoamine metabolite concentrations in CSF of healthy volunteers. Eur Arch Psychiatry Clin Neurosci 247 (1997) 297-302
17. Mendels J., Kiev A., and Fabre L.F. Double-blind comparison of citalopram and placebo in depressed outpatients with melancholia. Depress Anxiety 9 (1999) 54-60
18. Nielsen D.A., Goldman D., Virkkunen M., Tokola R., Rawlings R., and Linnoila M. Suicidality and 5-hydroxyindoleacetic acid concentration associated with a tryptophan hydroxylase polymorphism. Arch Gen Psychiatry 51 (1994) 34-38
19. Nierenberg A.A., and Wright E.C. Evolution of remission as the new standard in the treatment of depression. J Clin Psychiatry 60 (1999) 7-11 [Suppl 22]
20. Pickar D., and Rubinow K. Pharmacogenomics of psychiatric disorders. Trends Pharmacol Sci 22 (2001) 75-83
21. Rausch J.L., Johnson M.E., Fei Y.J., Li J.Q., Shendarkar N., Hobby H.M., et al. Initial conditions of serotonin transporter kinetics and genotype: influence on SSRI treatment trial outcome. Biol Psychiatry 51 (2002) 723-732
22. Rothman K.J. No adjustments are needed for multiple comparisons. Epidemiology 1 (1990) 43-46
23. Serretti A., Lilli R., Lorenzi C., Lattuada E., Cusin C., and Smeraldi E. Tryptophan hydroxylase gene and major psychoses. Psychiatry Res 10 (2001) 379-386
24. Serretti A., Zanardi R., Cusin C., Rossini D., Lorenzi C., and Smeraldi E. Tryptophan hydroxylase gene associated with paroxetine antidepressant activity. Eur Neuropsychopharmacol 11 (2001) 375-380
25. Serretti A., Zanardi R., Rossini D., Cusin C., Lilli R., and Smeraldi E. Influence of tryptophan hydroxylase and serotonin transporter genes on fluvoxamine antidepressant activity. Mol Psychiatry 6 (2001) 586-592
26. Smits K.M., Schouten J.S., Smits L.J., Stelma F.F., Nelemans P., and Prins M.H. A review on the design and reporting of studies on drug-gene interaction. J Clin Epidemiol 58 (2005) 651-654
27. Stahl S.M. Placebo-controlled comparison of the selective serotonin reuptake inhibitors citalopram and sertraline. Biol Psychiatry 48 (2000) 894-901
28. Viana M.M., De Marco L.A., Boson W.L., Romano-Silva M.A., and Correa H. Investigation of A218C tryptophan hydroxylase polymorphism: association with familial suicide behavior and proband's suicide attempt characteristics. Genes Brain Behav 5 (2006) 340-345
29. Yoshida K., Naito S., Takahashi H., Sato K., Ito K., Kamata M., et al. Monoamine oxidase: a gene polymorphism, tryptophan hydroxylase gene polymorphism and antidepressant response to fluvoxamine in Japanese patients with major depressive disorder. Prog Neuropsychopharmacol Biol Psychiatry 26 (2002) 1279-1283